TABLE 1.
C. neoformans strains tested in this study and results of immunoserotyping and molecular identification of the serotype
| Strain no. | Strain name | Isolationa
|
Immunologic serotyping
|
Molecular identification
|
|||
|---|---|---|---|---|---|---|---|
| Origin | Site | Methodb | Result | REA patternc | Fragment size(s) (bp)d | ||
| 1 | H99 | United States | CSF | Commercial kit | A | A | 394 |
| 2 | IHEM 11752 | Congo | CSF | Commercial kit | A | A | 400 |
| 3 | IHEM 11753 | Congo | CSF | Commercial kit | A | A | 394 |
| 4 | IHEM 11756 | Congo | CSF | Commercial kit | A | A | 394 |
| 5 | IHEM 11757 | Congo | CSF | Commercial kit | A | A | 394 |
| 6 | IHEM 11876 | Congo | CSF | Commercial kit | A | A | 394 |
| 7 | IHEM 11877 | Congo | CSF | Commercial kit | A | A | 394 |
| 8 | IHEM 11880 | Congo | CSF | Commercial kit | A | A | 394 |
| 9 | IHEM 11882 | Congo | CSF | Commercial kit | A | A | 394 |
| 10 | Tou | Mali | CSF | Homemade Ab | A | A | 394 |
| 11 | Fat | Congo | CSF | Homemade Ab | A | A | 400 |
| 12 | coc 119 | Cochin, India | CSF | Homemade Ab | A | A | 394 |
| 13 | 333 | Gabon | CSF | Homemade Ab | A | A | 394 |
| 14 | 2598 P | Ivory Coast | CSF | Homemade Ab | A | A | 394 |
| 15 | g 57497 | Gabon | CSF | Homemade Ab | A | A | 394 |
| 16 | Oug 1 | Uganda | CSF | Homemade Ab | A | A | 394 |
| 17 | PP38 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 18 | RV66254 | Rwanda | CSF | Homemade Ab | A | A | 394 |
| 19 | 3/768 | Congo | CSF | Homemade Ab | A | A | 394 |
| 20 | Lim | France | CSF | Homemade Ab | D | A | 394 |
| 21 | C3 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 22 | C6 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 23 | C7 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 24 | Oug 7 | Uganda | CSF | Homemade Ab | A | A | 394 |
| 25 | PP29 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 26 | RV68535 | Rwanda | CSF | Homemade Ab | A | A | 394 |
| 27 | RV68528 | Rwanda | CSF | Homemade Ab | A | A | 394 |
| 28 | Tnn Ci | France | CSF | Homemade Ab | A | A | 394 |
| 29 | g 59546 | Gabon | CSF | Homemade Ab | A | A | 394 |
| 30 | RV66254 | Rwanda | CSF | Homemade Ab | A | A | 394 |
| 31 | C57 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 32 | C68 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 33 | Oug 3 | Uganda | CSF | Homemade Ab | AD | A | 394 |
| 34 | Oug 9 | Uganda | CSF | Homemade Ab | A | A | 394 |
| 35 | PP43 | Cambodia | CSF | Homemade Ab | A | A | 394 |
| 36 | 241 | Gabon | CSF | Homemade Ab | A | A | 394 |
| 37 | Tnn Mb | France | Blood | mAb IF | A | A | 394 |
| 38 | Tnn Da | France | Blood | mAb IF | A | A | 394 |
| 39 | Tnn Mo | France | CSF | mAb IF | A | A | 394 |
| 40 | Bel | Belgium | CSF | Commercial kit | A | A | 394 |
| 41 | IHEM 4157 | Belgium | NS | Commercial kit | AD | AD | 382, 394 |
| 42 | IHEM 13877 | Belgium | CSF | Commercial kit | AD | AD | 382, 394 |
| 43 | IHEM 14440 | Belgium | CSF | Commercial kit | AD | AD | 382, 394 |
| 44 | IHEM 16079 | Belgium | Voice prosthesis | Commercial kit | AD | AD | 382, 394 |
| 45 | IHEM 16513 | Peru | CSF | Commercial kit | AD | AD | 382, 394 |
| 46 | IHEM 17861 | Peru | CSF | Commercial kit | AD | AD | 382, 394 |
| 47 | RV 66423 | Rwanda | CSF | Homemade Ab | A | D | 382 |
| 48 | JEC21 | NS | NS | Commercial kit | D | D | 382 |
| 49 | B 3501 A | NS | NS | Commercial kit | D | D | 382 |
| 50 | NIH D52 | United States | CSF | Commercial kit | D | D | 382 |
| 51 | IHEM 15038 | Peru | NS | Commercial kit | D | D | 382 |
| 52 | IHEM 18620 | Belgium | Skin | Commercial kit | D | D | 382 |
| 53 | IHEM 16711 | Belgium | Skin | Commercial kit | D | D | 382 |
| 54 | IHEM 4158 | Italy | NS | Commercial kit | D | D | 382 |
| 55 | AKD 30 | Ivory Coast | CSF | Homemade Ab | A | D | 380 |
| 56 | T 6073 | France | CSF | Homemade Ab | D | D | 382 |
| 57 | 2815 | Cambodia | CSF | Homemade Ab | A | D | 382 |
| 58 | Tnn Re | France | BAL fluid | mAb IF | D | D | 382 |
| 59 | JLP34 | France | CSF | mAb IF | D | D | 382 |
| 60 | JLP23 | France | Urine | mAb IF | D | D | 382 |
| 61 | IHEM 11758 | Congo | CSF | Commercial kit | D | D | 380 |
| 62 | C9 | Cambodia | CSF | Homemade Ab | A | D | 382 |
| 63 | IHEM 14934 | Brazil | NS | Commercial kit | B | B | 373 |
| 64 | IHEM 4161e | United States | Sputum | Commercial kit | B | B | 373 |
| 65 | IHEM 11796e | Zaire | CSF | Commercial kit | B | B | 373 |
| 66 | IHEM 4170 | Malaysia | NS | Commercial kit | B | B | 373 |
| 67 | IHEM 4164 | China | CSF | Commercial kit | B | B | 371 |
| 68 | WM 276 | Australia | Environment | Commercial kit | B | B | 371 |
| 69 | VanR265 | Canada | BWF | Commercial kit | B | B | 380 |
| 70 | RV68522 | Rwanda | CSF | Homemade Ab | D | B | 371 |
| 71 | IHEM 10079 | NS | CSF | Commercial kit | C | C | 366 |
| 72 | IHEM 4159e | United States | CSF | Commercial kit | C | C | 366 |
NS, not specified; CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; BWF, bronchial wash fluid; Congo, Democratic Republic of the Congo.
The commercial kit used was the Crypto Check kit (Iatron Labs, Tokyo, Japan). Homemade Ab, agglutination with homemade antisera (9); mAb IF, immunofluorescence with monoclonal antibody specific for CPS (3).
REA pattern deduced from in silico analysis (Table 2).
PCR fragments are supposed to be 8 bases longer than the sequences due to a 7-base tail added to the reverse primer used to promote the addition of an extra A to the amplified fragment.
Type strain.